Dobesh, Paul P <br/><br/>
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease.  [electronic resource] 

 -  Cardiovascular drugs and therapy  Aug 2017 
 - 433-444 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1573-7241 
<br/><br/><label>Standard No.: </label>10.1007/s10557-017-6749-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine--adverse effects<br/>Atherosclerosis--complications<br/>Cardiovascular Diseases--drug therapy<br/>Humans<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Purinergic P2Y Receptor Antagonists--adverse effects<br/>Thrombosis--prevention & control<br/>Ticagrelor